News

The company believes that the new OTC analgesic could provide an alternative to current OTC pain relievers. According to an August 2010 report published by the US Census

As part of the agreement, the two companies are developing joint operations and technology-transfer protocols and will implement an integrated approach to bring complex controlled-release products to market

Kiklin Capsules bind to phosphate in the gastrointestinal tract to decrease the serum phosphorus concentration, thereby hindering absorption of phosphate into the human body. The amine-functional polymers, Kiklin

The Pennsylvania facility will package some of the company’s products for cardiovascular and metabolic therapies including treatments for hypertension, heart disease, diabetes and hyperlipidemia. The 140,000ft² facility might

The pharmaceutical company will fund transdermal and subcutaneous drug absorption model in GastroPlus. Simulations Plus chairman and chief executive officer Walt Woltosz said the funded collaboration will extend

The fund will increase the company’s effort to perfect its nanoparticle-based siRNA delivery systems and speed up the IND enabling studies for STP705. Sirnaomics has developed nanoparticle-based siRNA

Baxter has been given Orphan Drug Designation in the US as MMN is present between one or two people for approximately 100,000 individuals. The approval was based on

A total of 24 adult patients with type 2 diabetes, on insulin or oral agents, with a body mass index of 25-40kg/m² and with an A1C of less

Under the agreement, Ana Darou gained exclusive rights to market and sell Nalox/Emtrix in Iran while Moberg assumes production and supply responsibility. Moberg Derma CEO and founder Peter